FDA rejects Replimune's melanoma therapy despite breakthrough designation, raising urgent questions about regulatory ...

US phase 3 ASTRA (NCT07368959) will enroll across ~12 sites, randomizing patients to a single intracameral administration of ...

Replimune disagrees with the FDA about whether the data set, upon which breakthrough therapy designation was awarded, is sufficient to allow this promising medicine to be made available to advanced ...

Anthropic asserted Tuesday that it's created a new era for cybersecurity after developing an artificial intelligence model ...

Mesoblast (NASDAQ:MESO) used its inaugural R&D Day to highlight the commercial progress of its first FDA-approved product, ...

The FDA has granted orphan drug Designation to tovecimig (CTX-009) for the treatment of patients with biliary tract cancer ...

Low-income patients receiving a debit card spent most of the money on things upstream of medical care like food and utilities ...

In the transfer portal era, it’s rare for a player to stick around for all four years. Senior Anna Zyryanova has been a big ...

Find the best new sweepstakes casinos in April 2026. Learn about the sweeps coins bonuses, games, reward systems, key ...